Search research articles
Contact Us
Filters
Showing results (201-210 of 236) with videos related to
Page
of 24
Sort By:
Clinical Chemistry and Laboratory Medicine
|
July 10, 2007
Proposal of a candidate international conventional reference measurement procedure for free thyroxine in serum
, Linda M Thienpont, Graham Beastall, et al.
ACS Medicinal Chemistry Letters
|
March 19, 2021
Identification of Potent Reverse Indazole Inhibitors for HPK1
Elsie C Yu, Joey L Methot, Xavier Fradera, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 15, 2021
Discovery of IDO1 inhibitors containing a decahydroquinoline, decahydro-1,6-naphthyridine, or octahydro-1H-pyrrolo[3,2-c]pyridine scaffold
Wensheng Yu, Yongqi Deng, David Sloman, et al.
Toxicology and Applied Pharmacology
|
September 2, 2020
Characterization of indoleamine-2,3-dioxygenase 1, tryptophan-2,3-dioxygenase, and Ido1/Tdo2 knockout mice
Amy G Aslamkhan, Qiuwei Xu, Amy Loughlin, et al.
Prehospital Emergency Care
|
October 3, 2024
Prehospital Delta Shock Index Predicts Mortality and Need for Life Saving Interventions in Trauma Patients
Philip W Walker, James F Luther, Stephen R Wisniewski, et al.
Cancer Immunology Research
|
February 21, 2020
Cancer-Associated Fibroblasts Promote Immunosuppression by Inducing ROS-Generating Monocytic MDSCs in Lung Squamous Cell Carcinoma
Handan Xiang, Carlo P Ramil, Josephine Hai, et al.
The Journal of Experimental Medicine
|
June 15, 2019
Mg<sup>2+</sup> regulation of kinase signaling and immune function
Chryssa Kanellopoulou, Alex B George, Evan Masutani, et al.
ACS Medicinal Chemistry Letters
|
September 17, 2021
Utilization of Metabolite Identification and Structural Data to Guide Design of Low-Dose IDO1 Inhibitors
Brett Hopkins, Hongjun Zhang, Indu Bharathan, et al.
ACS Medicinal Chemistry Letters
|
April 16, 2021
Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds
Brandon A Vara, Samuel M Levi, Abdelghani Achab, et al.
The Journal of Allergy and Clinical Immunology
|
November 28, 2015
RORγt inhibitors suppress T(H)17 responses in inflammatory arthritis and inflammatory bowel disease
Jelle de Wit, M Hussein Al-Mossawi, Michael H Hühn, et al.
Page
of 24
Search research articles
Search
Showing results (201-210 of 236) with videos related to
Sort By:
Page
of 24
Clinical Chemistry and Laboratory Medicine
|
July 10, 2007
Proposal of a candidate international conventional reference measurement procedure for free thyroxine in serum
, Linda M Thienpont, Graham Beastall, et al.
ACS Medicinal Chemistry Letters
|
March 19, 2021
Identification of Potent Reverse Indazole Inhibitors for HPK1
Elsie C Yu, Joey L Methot, Xavier Fradera, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 15, 2021
Discovery of IDO1 inhibitors containing a decahydroquinoline, decahydro-1,6-naphthyridine, or octahydro-1H-pyrrolo[3,2-c]pyridine scaffold
Wensheng Yu, Yongqi Deng, David Sloman, et al.
Toxicology and Applied Pharmacology
|
September 2, 2020
Characterization of indoleamine-2,3-dioxygenase 1, tryptophan-2,3-dioxygenase, and Ido1/Tdo2 knockout mice
Amy G Aslamkhan, Qiuwei Xu, Amy Loughlin, et al.
Prehospital Emergency Care
|
October 3, 2024
Prehospital Delta Shock Index Predicts Mortality and Need for Life Saving Interventions in Trauma Patients
Philip W Walker, James F Luther, Stephen R Wisniewski, et al.
Cancer Immunology Research
|
February 21, 2020
Cancer-Associated Fibroblasts Promote Immunosuppression by Inducing ROS-Generating Monocytic MDSCs in Lung Squamous Cell Carcinoma
Handan Xiang, Carlo P Ramil, Josephine Hai, et al.
The Journal of Experimental Medicine
|
June 15, 2019
Mg<sup>2+</sup> regulation of kinase signaling and immune function
Chryssa Kanellopoulou, Alex B George, Evan Masutani, et al.
ACS Medicinal Chemistry Letters
|
September 17, 2021
Utilization of Metabolite Identification and Structural Data to Guide Design of Low-Dose IDO1 Inhibitors
Brett Hopkins, Hongjun Zhang, Indu Bharathan, et al.
ACS Medicinal Chemistry Letters
|
April 16, 2021
Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds
Brandon A Vara, Samuel M Levi, Abdelghani Achab, et al.
The Journal of Allergy and Clinical Immunology
|
November 28, 2015
RORγt inhibitors suppress T(H)17 responses in inflammatory arthritis and inflammatory bowel disease
Jelle de Wit, M Hussein Al-Mossawi, Michael H Hühn, et al.
Page
of 24